|
70 Companies |
|
97 Products |
|
97 Products |
|
124 Mechanisms of Action |
|
1 Trial |
|
1962 News |
|
| «12...2425262728293031323334...3940» |
- phenobarbital / Generic mfg., clonidine / Generic mfg.
Enrollment change: Clonidine for Neonatal Abstinence Syndrome Study (clinicaltrials.gov) - Jul 1, 2013
P=N/A, N=68, Terminated, Sponsor: Baystate Medical Center
N=110 --> 68
- Enrollment change: GAINS: Gabapentin for Abstinence Initiation in Alcohol Dependence (clinicaltrials.gov) - Jul 1, 2013
P2/3, N=40, Completed, Sponsor: New York State Psychiatric Institute
N=110 --> 68 N=60 --> 40
- Compliance: MAPIT: Motivational Assessment Program to Initiate Treatment (clinicaltrials.gov) - Jul 1, 2013
P=N/A, N=600, Recruiting, Sponsor: University of North Texas Health Science Center
- Enrollment open: Safety & Prevention Outcomes Study (clinicaltrials.gov) - Jul 1, 2013
P=N/A, N=200, Recruiting, Sponsor: University of Michigan
N=60 --> 40 Not yet recruiting --> Recruiting
- Trial completion: GAINS: Gabapentin for Abstinence Initiation in Alcohol Dependence (clinicaltrials.gov) - Jul 1, 2013
P2/3, N=40, Completed, Sponsor: New York State Psychiatric Institute
Not yet recruiting --> Recruiting Recruiting --> Completed
- | methamphetamine / Generic mfg., mirtazapine / Generic mfg.
New P2 trial: Mirtazapine for the Treatment of Methamphetamine Dependence Among MSM (M2.0) (clinicaltrials.gov) - Jun 26, 2013
P2, N=120, Recruiting, Sponsor: Phillip Coffin, MD, MIA
- ||||| New P2 trial: Efficacy and Safety of TV-1380 as Treatment for Facilitation of Abstinence in Cocaine-Dependent Subjects (clinicaltrials.gov) - Jun 24, 2013
P2, N=210, Active, not recruiting, Sponsor: Teva Pharmaceutical Industries
- Enrollment closed: Project SERVE: Post Deployment Functioning (clinicaltrials.gov) - Jun 23, 2013
P=N/A, N=309, Active, not recruiting, Sponsor: Department of Veterans Affairs
Recruiting --> Completed Recruiting --> Active, not recruiting
- Enrollment change: Development and Testing of Adolescent Twelve-Step Facilitation (clinicaltrials.gov) - Jun 20, 2013
P=N/A, N=60, Recruiting, Sponsor: Massachusetts General Hospital
Recruiting --> Active, not recruiting N=40 --> 60
- bupropion sustained-release / Generic mfg.
Trial completion: Nicotine Patch Pretreatment for Smoking Cessation in PTSD (clinicaltrials.gov) - Jun 19, 2013
P0, N=87, Completed, Sponsor: Department of Veterans Affairs
N=40 --> 60 Active, not recruiting --> Completed
- Chantix (varenicline) / Pfizer
Trial termination: Varenicline and Alcohol in Inpatient Addictions Program (IAP) (clinicaltrials.gov) - Jun 16, 2013
P3, N=1, Terminated, Sponsor: Mayo Clinic
Active, not recruiting --> Completed Enrolling by invitation --> Terminated
- Chantix (varenicline) / Pfizer
Enrollment change: Varenicline and Alcohol in Inpatient Addictions Program (IAP) (clinicaltrials.gov) - Jun 16, 2013
P3, N=1, Terminated, Sponsor: Mayo Clinic
Enrolling by invitation --> Terminated N=30 --> 1
- fluoxetine / Generic mfg.
Enrollment change: FIDAA: Pharmacological Intervention Project (Fluoxetine) (clinicaltrials.gov) - Jun 16, 2013
P2, N=50, Completed, Sponsor: University of Pittsburgh
N=30 --> 1 N=106 --> 50
- | clomifene citrate / Generic mfg.
New P2 trial: Clomiphene Citrate for the Treatment of Low Testosterone Associated With Chronic Opioid Pain Medication Administration (clinicaltrials.gov) - Jun 16, 2013
P2, N=134, Recruiting, Sponsor: Weill Medical College of Cornell University
- Chantix (varenicline) / Pfizer
Enrollment open, HEOR: Helping HAND2: Comparative Effectiveness of Post-Discharge Strategies for Hospitalized Smokers (clinicaltrials.gov) - Jun 16, 2013
P4, N=1350, Recruiting, Sponsor: Massachusetts General Hospital
N=106 --> 50 Not yet recruiting --> Recruiting
- fluoxetine / Generic mfg.
Trial completion: CADY: Effectiveness of Fluoxetine in Young People for the Treatment of Major Depression and Marijuana Dependence (clinicaltrials.gov) - Jun 16, 2013
P2, N=70, Completed, Sponsor: University of Pittsburgh
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- fluoxetine / Generic mfg.
Trial completion: FIDAA: Pharmacological Intervention Project (Fluoxetine) (clinicaltrials.gov) - Jun 16, 2013
P2, N=50, Completed, Sponsor: University of Pittsburgh
Active, not recruiting --> Completed Active, not recruiting --> Completed
- gemfibrozil / Generic mfg.
New P2 trial: Initial Screening of Gemfibrozil as a Novel Treatment for Tobacco Addiction (clinicaltrials.gov) - Jun 11, 2013
P2, N=40, Recruiting, Sponsor: Centre for Addiction and Mental Health
- New P1 trial: Integrated CBT for Cannabis Dependence With Co-occurring Anxiety Disorders (clinicaltrials.gov) - Jun 10, 2013
P1, N=72, Recruiting, Sponsor: Louisiana State University and A&M College
- Emsam (selegiline transdermal) / Viatris
Trial completion: Selegiline Patch for Treatment of Nicotine Dependence (clinicaltrials.gov) - Jun 10, 2013
P2, N=230, Completed, Sponsor: Stanford University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Interactions Between Physical Activity and Cannabis Use in Adults (clinicaltrials.gov) - Jun 10, 2013
P=N/A, N=30, Completed, Sponsor: Vanderbilt University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||| New P2 trial: REVIVE(Randomized Exploratory Clinical Trial to Evaluate the Safety and Effectiveness of Stem Cell Product in Alcoholic Liver Cirrhosis Patient) (clinicaltrials.gov) - Jun 9, 2013
P2, N=72, Recruiting, Sponsor: Pharmicell Co., Ltd.
- Enrollment open: Integrated CBT for Cannabis Dependence With Co-occurring Anxiety Disorders (clinicaltrials.gov) - Jun 9, 2013
P1, N=72, Recruiting, Sponsor: Louisiana State University and A&M College
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Trial initiation date: Pilot Clinical Trial of Computer-based Motivational Intervention - 1 (clinicaltrials.gov) - Jun 5, 2013
P1, N=30, Completed, Sponsor: Wayne State University
Not yet recruiting --> Recruiting Initiation date: Sep 2001 --> Oct 2004
- Trial completion: Pilot Clinical Trial of Computer-based Motivational Intervention - 1 (clinicaltrials.gov) - Jun 5, 2013
P1, N=30, Completed, Sponsor: Wayne State University
Initiation date: Sep 2001 --> Oct 2004 Not yet recruiting --> Completed
- ||| buprenorphine/naloxone sublingual film / Generic mfg., buprenorphine sublingual tablets / Generic mfg.
Enrollment closed: Transfer of Subjects From Subutex/Suboxone to RBP-6300 (clinicaltrials.gov) - Jun 4, 2013
P2, N=143, Active, not recruiting, Sponsor: Reckitt Benckiser Pharmaceuticals Inc.
Not yet recruiting --> Completed Recruiting --> Active, not recruiting
- Enrollment closed: An Effectiveness Trial of Maintenance Therapy for Nicotine Dependence (clinicaltrials.gov) - Jun 4, 2013
P4, N=525, Active, not recruiting, Sponsor: University of Pennsylvania
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Trial completion: Cognitive Enhancement and Relapse Prevention in Cocaine Addiction (clinicaltrials.gov) - May 29, 2013
P=N/A, N=85, Completed, Sponsor: University of Arkansas
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Trial initiation date: PACT: Protect and Connect: Couple HIV Prevention for Drug Involved Male Offenders (clinicaltrials.gov) - May 28, 2013
P=N/A, N=480, Recruiting, Sponsor: Columbia University
Active, not recruiting --> Completed Initiation date: Feb 2013 --> Jun 2013
- ondansetron intravenous / Generic mfg.
Trial completion: Zofran_PK: How Pregnant Women and Their Babies Metabolize Ondansetron Compared to a Group of Non-pregnant Women (clinicaltrials.gov) - May 27, 2013
P1/2, N=100, Completed, Sponsor: Stanford University
Initiation date: Feb 2013 --> Jun 2013 Recruiting --> Completed
- Enrollment change: PTSC: Persistence-Targeted Smoking Cessation (clinicaltrials.gov) - May 23, 2013
P1, N=50, Recruiting, Sponsor: Rutgers, The State University of New Jersey
Recruiting --> Completed N=10 --> 50
- methamphetamine / Generic mfg.
Enrollment change: MARC: "The Evaluation of Stimulant Withdrawal" (clinicaltrials.gov) - May 23, 2013
P2, N=0, Withdrawn, Sponsor: Aaron J. Janowsky
N=10 --> 50 N=80 --> 0
- Enrollment closed: Research on Outpatient Adolescent Treatment for Comorbid Substance Use and Internalizing Disorders (clinicaltrials.gov) - May 20, 2013
P2, N=160, Active, not recruiting, Sponsor: Medical University of South Carolina
N=80 --> 0 Recruiting --> Active, not recruiting
- Trial completion: D-Cycloserine Facilitation of Cocaine - Cue Extinction (clinicaltrials.gov) - May 20, 2013
P2, N=79, Completed, Sponsor: Medical University of South Carolina
Recruiting --> Active, not recruiting Recruiting --> Completed
- Biomarker: Tobacco Cessation: Treatment Delivery and Predictors of Outcome (clinicaltrials.gov) - May 19, 2013
P=N/A, N=1000, Recruiting, Sponsor: National Institute on Drug Abuse (NIDA)
- Vivitrol (naltrexone extended-release injectable suspension) / Alkermes
New P3 trial: Oral vs. Injectable Naltrexone for Hospitalized Veterans With Alcohol Dependence (clinicaltrials.gov) - May 15, 2013
P3, N=50, Not yet recruiting, Sponsor: University of Wisconsin, Madison
- Enrollment open: Primary Care-Based Interventions to Reduce Alcohol Use Among HIV Patients (clinicaltrials.gov) - May 15, 2013
P=N/A, N=600, Recruiting, Sponsor: University of California, San Francisco
Recruiting --> Completed Not yet recruiting --> Recruiting
- | New P2 trial: Use of Kudzu Extract in the Study of Its Ability to Reduce Alcohol Drinking in Treatment Seeking Alcohol Dependent Persons (clinicaltrials.gov) - May 12, 2013
P2, N=116, Not yet recruiting, Sponsor: Mclean Hospital
- | baclofen / Generic mfg.
Trial initiation date: BacALD: Baclofen in the Treatment of Alcohol Dependence With or Without Alcoholic Liver Disease (clinicaltrials.gov) - May 7, 2013
P3, N=180, Recruiting, Sponsor: South West Sydney Local Health District
Not yet recruiting --> Recruiting Initiation date: Oct 2012 --> Mar 2013
- | baclofen / Generic mfg.
Enrollment change: BacALD: Baclofen in the Treatment of Alcohol Dependence With or Without Alcoholic Liver Disease (clinicaltrials.gov) - May 7, 2013
P3, N=180, Recruiting, Sponsor: South West Sydney Local Health District
Initiation date: Oct 2012 --> Mar 2013 N=120 --> 180
- | baclofen / Generic mfg.
Enrollment open: BacALD: Baclofen in the Treatment of Alcohol Dependence With or Without Alcoholic Liver Disease (clinicaltrials.gov) - May 7, 2013
P3, N=180, Recruiting, Sponsor: South West Sydney Local Health District
N=120 --> 180 Not yet recruiting --> Recruiting
- nepicastat (APL-1401) / Asieris
Enrollment open: A Multi-Center Trial of Nepicastat for Cocaine Dependence (clinicaltrials.gov) - May 7, 2013
P2, N=180, Recruiting, Sponsor: National Institute on Drug Abuse (NIDA)
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- ||| Trial completion: Integrated Behavioral Intervention for Cigarette Smoking and Binge Drinking in Young Adults (clinicaltrials.gov) - May 7, 2013
P=N/A, N=170, Completed, Sponsor: Mayo Clinic
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- |||||||||| Zubsolv (buprenorphine/naloxone sublingual tablet) / Orexo, Mundipharma
New P3 trial, Head-to-Head: Study to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid Dependence (clinicaltrials.gov) - May 5, 2013
P3, N=310, Completed, Sponsor: Orexo AB
- Enrollment change: Caffeine and Cocaine (clinicaltrials.gov) - May 2, 2013
P1/2, N=67, Completed, Sponsor: The University of Texas Health Science Center, Houston
Active, not recruiting --> Completed N=30 --> 67
- | New P2 trial: Evaluation of an School-based Alcohol Prevention Program for Middle School Students (clinicaltrials.gov) - May 2, 2013
P2, N=2300, Recruiting, Sponsor: Oregon Research Institute
- Trial completion: Caffeine and Cocaine (clinicaltrials.gov) - May 2, 2013
P1/2, N=67, Completed, Sponsor: The University of Texas Health Science Center, Houston
N=30 --> 67 Recruiting --> Completed
- Trial completion: Impulsivity, Brain Function, and Substance Abuse Treatment in Cocaine Dependent Individuals (clinicaltrials.gov) - May 2, 2013
P2, N=192, Completed, Sponsor: The University of Texas Health Science Center, Houston
Recruiting --> Completed Recruiting --> Completed
- Trial initiation date: STED-CD: D-Serine for Cocaine Dependence Pilot (clinicaltrials.gov) - May 1, 2013
P2, N=0, Withdrawn, Sponsor: Theresa Winhusen
Recruiting --> Completed Initiation date: Oct 2013 --> Feb 2014
- | cocaine esterase (TNX-1300) / Tonix
New P2 trial: A Randomized, 4-sequence, 2-period, Double-blind, Placebo Controlled Study With a DSM-IV-TR Diagnosis of Cocaine Abuse (clinicaltrials.gov) - May 1, 2013
P2, N=28, Active, not recruiting, Sponsor: Reckitt Benckiser Pharmaceuticals Inc.